Skip to main content

Table 5 Association of HLA-DR3 and DERAA-encoding alleles stratified by the presence of shared epitope alleles with ACPA+ rheumatoid arthritis

From: Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor

  

Controls

(n = 269)

ACPA-positive RA patients

(n = 143)

    

Pvalue

OR (95% CI)

SE-positive

DR3-positive

16 (14.3)

8 (8.2)

0.17

0.53 (0.22-1.22)

 

DR3-negative

96 (85.7)

89 (91.8)

  

SE-negative

DR3-positive

37 (23.6)

10 (21.7)

0.84

0.90 (0.40-1.98)

 

DR3-negative

120 (76.4)

36 (78.3)

  

SE-positive

DERAA-positive

14 (12.5)

10 (10.3)

0.85

0.58 (0.34-1.90)

 

DERAA-negative

98 (87.5)

87 (89.7)

  

SE-negative

DERAA-positive

58 (36.9)

15 (32.6)

0.72

0.82 (0.41-1.65)

 

DERAA-negative

99 (63.1)

31 (67.4)

  
  1. Percentages relate to total SE-positive or SE-negative controls.
  2. ACPA, anti-citrullinated protein antibody; CI, confidence interval; DERAA, DERAA-encoding allele; DR3, HLA-DR3; OR, odds ratio; RA, rheumatoid arthritis; SE, shared epitope allele.